UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

On the gene expression landscape of cancer

PloS one, 2023-02, Vol.18 (2), p.e0277786-e0277786

2023

Volltextzugriff (PDF)

Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy

Infectious disorders drug targets, 2019, Vol.19 (1), p.2-16

2019

Volltextzugriff (PDF)

A self-consistent probabilistic formulation for inference of interactions

Scientific reports, 2020-12, Vol.10 (1), p.21435-16, Article 21435

2020

Volltextzugriff (PDF)

Rapid identification of diarrheagenic Escherichia coli based on barcoded magnetic bead hybridization

Chinese chemical letters, 2020-07, Vol.31 (7), p.1812-1816

2020

Volltextzugriff (PDF)

CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome

Molecular and cellular biochemistry, 2020-07, Vol.470 (1-2), p.63-75

2020

Volltextzugriff (PDF)

Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines

BMC genomics, 2023-07, Vol.24 (1), p.373-373, Article 373

2023

Volltextzugriff (PDF)

Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination

International journal of peptide research and therapeutics, 2021-12, Vol.27 (4), p.2873-2882

2021

Volltextzugriff (PDF)

The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality

Viruses, 2024-03, Vol.16 (3), p.418

2024

Volltextzugriff (PDF)

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

Scientific reports, 2020-09, Vol.10 (1), p.14689-14689, Article 14689

2020

Volltextzugriff (PDF)

Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach

Molecular medicine (Cambridge, Mass.), 2021-12, Vol.27 (1), p.161-18, Article 161

2021

Volltextzugriff (PDF)

CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells

Viruses, 2022-07, Vol.14 (8), p.1681

2022

Volltextzugriff (PDF)

A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response

Vaccines (Basel), 2024-05, Vol.12 (6), p.588

2024

Volltextzugriff (PDF)

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection

Viruses, 2022-03, Vol.14 (3), p.552

2022

Volltextzugriff (PDF)

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support

Cancers, 2020-05, Vol.12 (6), p.1377

2020

Volltextzugriff (PDF)

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

Biomedicines, 2021-07, Vol.9 (7), p.766

2021

Volltextzugriff (PDF)

CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition

Frontiers in molecular biosciences, 2022-03, Vol.9, p.834814-834814

2022

Volltextzugriff (PDF)

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model

Biomedicines, 2022-12, Vol.11 (1), p.43

2022

Volltextzugriff (PDF)

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

Cells (Basel, Switzerland), 2021-02, Vol.10 (2), p.338

2021

Volltextzugriff (PDF)

Positive effects of Phycocyanobilin on gene expression in glutamate-induced excitotoxicity in SH-SY5Y cells and animal models of multiple sclerosis and cerebral ischemia

Heliyon, 2022-06, Vol.8 (6), p.e09769-e09769, Article e09769

2022

Volltextzugriff (PDF)

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

Molecular cancer therapeutics, 2009-05, Vol.8 (5), p.1189-1196

2009

Volltextzugriff (PDF)

The Combination of the CIGB-300 Anticancer Peptide and Cisplatin Modulates Proteins Related to Cell Survival, DNA Repair and Metastasis in a Lung Cancer Cell Line Model

Current proteomics, 2019-01, Vol.16 (4), p.338-349

2019

Volltextzugriff (PDF)

Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models

Molecular and clinical oncology, 2014-11, Vol.2 (6), p.935-944

2014

Volltextzugriff (PDF)

CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation

Seminars in oncology, 2018-01, Vol.45 (1-2), p.58-67

2018

Volltextzugriff (PDF)

Development and validation of a quantitative ELISA for the measurement of PSA concentration

Clinica chimica acta, 2002-03, Vol.317 (1), p.55-63

2002

Volltextzugriff (PDF)

Reajuste de densidad aparente y retención de carbono: Modelos idoneos para arenas cubanas

M+A : Revista Electrónica de Medioambiente, 2017-07, Vol.18 (2), p.117

2017

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(64)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

On the gene expression landscape of cancer

Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy

A self-consistent probabilistic formulation for inference of interactions

Rapid identification of diarrheagenic Escherichia coli based on barcoded magnetic bead hybridization

CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome

Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines

Evaluation of Cell-Penetrating Peptides as Mucosal Immune Enhancers for Nasal Vaccination

The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach

CIGB-300 Peptide Targets the CK2 Phospho-Acceptor Domain on Human Papillomavirus E7 and Disrupts the Retinoblastoma (RB) Complex in Cervical Cancer Cells

A Nasal Vaccine Candidate, Containing Three Antigenic Regions from SARS-CoV-2, to Induce a Broader Response

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection

Clinical-Grade Peptide-Based Inhibition of CK2 Blocks Viability and Proliferation of T-ALL Cells and Counteracts IL-7 Stimulation and Stromal Support

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

Positive effects of Phycocyanobilin on gene expression in glutamate-induced excitotoxicity in SH-SY5Y cells and animal models of multiple sclerosis and cerebral ischemia

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

The Combination of the CIGB-300 Anticancer Peptide and Cisplatin Modulates Proteins Related to Cell Survival, DNA Repair and Metastasis in a Lung Cancer Cell Line Model

Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models

CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation

Development and validation of a quantitative ELISA for the measurement of PSA concentration

Reajuste de densidad aparente y retención de carbono: Modelos idoneos para arenas cubanas

Suchergebnisse filtern